financetom
Business
financetom
/
Business
/
NCLAT stays eviction of Sterling Biotech from its premise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NCLAT stays eviction of Sterling Biotech from its premise
Aug 4, 2019 7:23 AM

The National Company Law Appellate Tribunal (NCLAT) has stayed eviction of Sterling Biotech from its premises as the debt-ridden company was going under the insolvency resolution process and was under the moratorium period.

A two-member bench headed by NCLAT Chairman Justice SJ Mukhopadhaya upheld the order passed by the Mumbai Bench of the National Company Law Tribunal (NCLT), which had asked Srei Infrastructure Finance, a financial creditor, to hand over the possession of the A and B wing premises of Laxmi Towers.

The appellate tribunal observed that although Sterling Biotech, which is presently going through liquidation, is not the owner of the premises it cannot be ejected or disturbed during the moratorium period as the company has to remain as a going concern.

"We hold that the Adjudicating Authority (NCLT) has rightly directed the Appellant to hand over the possession of B' Wing premises of Lakshmi Towers and rightly prohibited the Appellant from evicting the Corporate Debtor (Sterling Biotech) from A' Wing premises of Lakshmi Towers," said NCLAT.

However, it also said that "So far as the question as to who is the owner of A' and B' Wings premises of Lakshmi Towers and whether the Appellant has any right over the said property, such questions are not required to be determined in the proceeding under the I&B Code'."

NCLAT also said if Sterling Biotech is saved during the liquidation proceeding or if it is sold to a third party along with the employees then, in such case, one may move before the Competent Court of law for appropriate decision.

Besides, the appellate tribunal also said that "the Liquidator cannot sell the assets of the premises in question."

Resolution Professional of Sterling Biotech had moved NCLT against the financial creditor to return the possession of B Wing premises of Lakshmi Towers and restrain Srei Infrastructure Finance from taking any action in relation to A Wing premises, which had allowed it.

Following which, Srei Infrastructure Finance moved NCLAT.

It had contended that the property in question does not belong to Sterling Biotech and being a third party property, the order of Moratorium' passed under Section 14 of the I&B Code' will not be applicable.

Opposing it, the RP had submitted that it amounts to obstruction in the matter of keeping Sterling Biotech as a going concern.

Sterling Biotech, whose promoters Nitin Jayantilal Sandesara and Chetankumar Jayantilal Sandesara are absconding, has a total debt of over Rs 9,000 crore.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cameco Down 0.1% In US After Hours As Announces $500 Million Debenture Offering by Private Placement
Cameco Down 0.1% In US After Hours As Announces $500 Million Debenture Offering by Private Placement
May 21, 2024
05:11 PM EDT, 05/21/2024 (MT Newswires) -- Cameco ( CCJ ) announced after trade Tuesday that it has priced a private placement of senior unsecured debentures consisting of $500 million principal amount of 4.94% Senior Unsecured Debentures, Series I maturing on May 24, 2031. The closing of the offering is expected to take place on May 24, 2024. Cameco (...
Morningstar Insider Sold Shares Worth $2,853,561, According to a Recent SEC Filing
Morningstar Insider Sold Shares Worth $2,853,561, According to a Recent SEC Filing
May 21, 2024
05:09 PM EDT, 05/21/2024 (MT Newswires) -- Joseph D Mansueto, 10% Owner, Director, Executive Chairman, on May 17, 2024, sold 9,519 shares in Morningstar ( MORN ) for $2,853,561. Following the Form 4 filing with the SEC, Mansueto has control over a total of 15,590,594 shares of the company, with 10,687,931 shares held directly and 4,902,663 controlled indirectly. SEC Filing:...
Arthur J. Gallagher & Co Insider Sold Shares Worth $1,310,904, According to a Recent SEC Filing
Arthur J. Gallagher & Co Insider Sold Shares Worth $1,310,904, According to a Recent SEC Filing
May 21, 2024
05:13 PM EDT, 05/21/2024 (MT Newswires) -- Douglas K Howell, Vice President & Chief Financial Officer, on May 17, 2024, sold 5,100 shares in Arthur J. Gallagher & Co ( AJG ) for $1,310,904. Following the Form 4 filing with the SEC, Howell has control over a total of 79,384 shares of the company, with 75,852 shares held directly and...
GoDaddy Plans to Refinance Loans
GoDaddy Plans to Refinance Loans
May 21, 2024
05:11 PM EDT, 05/21/2024 (MT Newswires) -- GoDaddy ( GDDY ) and certain of its subsidiaries allocated a $1 billion tranche of term loans maturing in 2031 and plan to refinance and extend all outstanding tranche B-4 loans and up to $278 million of tranche B-6 term loans, GoDaddy ( GDDY ) said Tuesday. The transactions are expected to close...
Copyright 2023-2026 - www.financetom.com All Rights Reserved